CLINICAL CASE: THERAPY WITH SILDENAFIL IN THE TREATMENT OF IDIOPATHIC PULMONARY HYPERTENSION
https://doi.org/10.38109/2225-1685-2015-4-40-47
Abstract
The patient with the verified diagnosis of idiopathic pulmonary hypertension, negative acute vasoreactivity testing by RHC, functional class III (WHO) was treated by phosphodiesterase type 5 inhibitor sildenafil. After one year there was achieved the significant improvement of the functional and hemodynamic status.
About the Authors
Z. S. Valieva
Russian Cardiology Research and Production Complex, Scientific research institute of a cardiology of A. L. Myasnikov
Russian Federation
Russian Federation
Z. H. Dadacheva
Russian Cardiology Research and Production Complex, Scientific research institute of a cardiology of A. L. Myasnikov
Russian Federation
Russian Federation
T. V. Martynyuk
Russian Cardiology Research and Production Complex, Scientific research institute of a cardiology of A. L. Myasnikov
Russian Federation
Russian Federation
N. M. Danilov
Russian Cardiology Research and Production Complex, Scientific research institute of a cardiology of A. L. Myasnikov
Russian Federation
Russian Federation
M. A. Saidova
Russian Cardiology Research and Production Complex, Scientific research institute of a cardiology of A. L. Myasnikov
Russian Federation
Russian Federation
I. Ye. Chazova
Russian Cardiology Research and Production Complex, Scientific research institute of a cardiology of A. L. Myasnikov
Russian Federation
Russian Federation
References
1. Диагностика и лечение лёгочной гипертензии. Российские рекомендации. Кардиоваскулярная терапия и профилактика (Прил. 2). 2007;
2. D’Alonzo G.E., Barst R.J., Ayres S.M. et al. Survival in patients with primary pulmonary hypertension. Results from a national prospective registry. Ann Intern Med 1991; 115:343-9.
3. Guidelines for the diagnosis and treatment of pulmonary hypertension. The task force for the diagnosis and treatment of pulmonary hypertension of the ECS and ERS, endorsed by the ISHLT. Eur Heart J 2009; 30:2493-537.
4. Беленков Ю.Н., Чазова И.Е. Первичная лёгочная гипертензия. М., 1991.
5. Galie N., Hoeper M.M., Humbert M. et al. ESC Committee for Practice Guidelines (CPG). Guidelines for the diagnosis and treatment of pulmonary hypertension: The Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS), endorsed by the International Society of Heart and Lung Transplantation (ISHLT). Eur Heart J 2009; 30:2493-537
6. McLaughlin V.V., Archer S., Badesch D.B. et al. ACCF/AHA 2009 Expert Consensus Document on Pulmonary Hypertension: A Report of the American College of Cardiology Foundation Task Force of Expert Consensus Documents and the American Heart Association Developed in Collaboration With the American College of Chest Physicians; American Thoracic Society and the Pulmonary Hypertension Association. J Am Coll Cardiol 2009; 53:1573-619.
7. Чазова И.Е., Авдеев С.Н., Царева Н.А. и др. Клинические рекомендации по диагностике и лечению лёгочной гипертензии. Терапевт. архив. 2014; 86 (9): 4-23
Review
For citations:
Valieva Z.S., Dadacheva Z.H., Martynyuk T.V., Danilov N.M., Saidova M.A., Chazova I.Ye. CLINICAL CASE: THERAPY WITH SILDENAFIL IN THE TREATMENT OF IDIOPATHIC PULMONARY HYPERTENSION. Eurasian heart journal. 2015;(4):40-47. (In Russ.) https://doi.org/10.38109/2225-1685-2015-4-40-47
Views:
309
Email this article 
